GIUFFRE', Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 4.146
EU - Europa 3.580
AS - Asia 657
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 8.389
Nazione #
US - Stati Uniti d'America 4.141
IE - Irlanda 1.146
SE - Svezia 922
CN - Cina 620
UA - Ucraina 409
DE - Germania 287
IT - Italia 205
FI - Finlandia 175
GB - Regno Unito 143
BE - Belgio 89
PL - Polonia 86
AT - Austria 78
RU - Federazione Russa 21
IN - India 17
VN - Vietnam 12
FR - Francia 9
CZ - Repubblica Ceca 7
CA - Canada 5
IR - Iran 4
BR - Brasile 3
EU - Europa 2
IQ - Iraq 2
PT - Portogallo 2
AU - Australia 1
CH - Svizzera 1
JP - Giappone 1
TW - Taiwan 1
Totale 8.389
Città #
Dublin 1.146
Chandler 927
Jacksonville 895
Nyköping 443
Beijing 297
Princeton 185
Ann Arbor 179
Cambridge 171
Dearborn 158
Medford 139
Des Moines 137
Boardman 98
Brussels 89
Warsaw 86
Ashburn 74
Vienna 67
Messina 66
Jinan 51
Lancaster 49
Woodbridge 43
Nanjing 38
Wilmington 38
Bremen 30
Shenyang 29
San Mateo 26
Hangzhou 24
Hebei 24
Haikou 18
Ningbo 18
Taizhou 18
Tianjin 17
Houston 15
Dong Ket 12
Nanchang 12
Washington 12
Norwalk 11
Falls Church 10
Auburn Hills 9
Changsha 9
Fuzhou 9
Jiaxing 8
Leawood 8
Mumbai 8
Reggio Calabria 8
Guangzhou 7
Brno 6
Genova 6
Helsinki 6
Mountain View 6
Rome 6
Saint Petersburg 6
Augusta 5
Catanzaro 5
Lanzhou 5
Taiyuan 5
Zhengzhou 5
Los Angeles 4
Redwood City 4
Clearwater 3
Edinburgh 3
Pieve di Soligo 3
São Paulo 3
Tappahannock 3
Ardabil 2
Hefei 2
Lisbon 2
Lissone 2
Milan 2
Montebelluna 2
Najaf 2
Naples 2
Novokuznetsk 2
Redmond 2
Riva 2
Siracusa 2
Strasbourg 2
Ascoli Piceno 1
Austin 1
Bari 1
Boston 1
Caltagirone 1
Concordia Sulla Secchia 1
Cormeilles-en-Parisis 1
Cupertino 1
Easton 1
Foggia 1
Fredericton 1
Henderson 1
Hillsdale 1
Kemerovo 1
Kunming 1
Lappeenranta 1
London 1
Longueuil 1
Lucera 1
Meieki 1
Mestrino 1
Molise 1
Monmouth Junction 1
New York 1
Totale 5.852
Nome #
Human epidermal growth factor receptor 2 status in gastric carcinomas with distinctive prevalent cribriform component 97
Confronto tra le anomalie citologiche e colposcopiche e il Test per la tipizzazione dell’HPV per la prevenzione del cervicocarcinoma in una popolazione adolescenziale della città di Messina. 94
Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening 91
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 83
Detection and genotyping of human papillomavirus in gynaecologic outpatients of Messina, eastern Sicily, Italy. 76
HER-2 overexpression in advanced node-positive gastric carcinomas: is there any relationship with other clinico-pathological histoprognostic parameters? 76
Relationship between the presence of high risk HPV DNA and proliferation rate in cervical intraepithelial neoplasia 74
Immunoexpression of lactoferrin in bone metastases and corresponding primary carcinomas. 74
Unexpected cytological diagnosis of two cases of echinococcosis. 72
Lactoferrin expression in colorectal cancer: relationships with proliferation indices and survival. 72
Pre-metastatic niche identification in node negative breast cancer to assess metastasis risk. Pathological and clinical implications. 72
Inusuale localizzazione leucemica a sede mammaria 72
BRAF mutation testing on melanoma brain metastases 71
MINUTE AND SMALL EARLY GASTRIC-CARCINOMA WITH SPECIAL REFERENCE TO EOSINOPHIL INFILTRATION 70
HER-2 overexpression in unusual histotypes of gastric carcinomas. 70
Immunohistochemical study of HER-2 overexpression in indolent gastric carcinomas. 70
Prognostic significance of standardized AgNor analysis in early and advanced gastric carcinomas. 69
Preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes for the assessment of metastasis risk in breast cancer (BC). 69
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 68
Immunohistochemical evidence of metallothionein in neoplasms of liver, gallbladder and pancreas 67
Adiponectin receptors expression is associated with an intestinal histotype and a longer survival in gastric carcinoma. 66
AgNOR quantity as a prognostic tool in hyperplastic and neoplastic parathyroid glands 62
Clearance and persistence of human papillomavirus infections in patients with lesions of the cervix 62
Immunohistochemical expression of autophagy-related proteins in advanced tubular gastric adenocarcinomas and its implications 62
An immunohistochemical investigation of pre-metastatic niche (PMN) in node-negative invasive breast carcinomas 61
AgNOR ANALYSIS OF ACTINIC KERATOSIS, BASAL AND SQUAMOUS CELL CARCINOMAS OF THE SKIN 60
Immunohistochemical demonstration of metallothionein in eyes with choroidal melanomas 59
Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis. 58
Actinic keratosis associated with squamous and basal cell carcinomas: an evaluation of neoplastic progression by a standardized AgNOR analysis. 58
AgNOR quantity in actinic keratosis and squamous cell carcinoma of the skin 57
Microvessels density evaluation in human meningiomas: an immunohistochemical investigation by the specific marker for neoangiogenesis CD105 (Endoglin). 57
Caveolin-1 in meningiomas: expression and clinico-pathological correlations 57
L'angiodisplasia del tenue, una causa rara di emorragia digestiva. 57
BRAF mutation testing on melanoma brain metastases 57
Immunoexpression of cyclooxygenase (COX)-2 in long-standing ulcerative colitis. 57
Human papillomavirus typing in gynaecologic outpatients in Messina, Italy. 57
Rilievi immunoistochimici sull'antigene CA 19-9 nei carcinomi della colecisti. 56
Analysis of genomic low copy number DNA from cells harvested by laser-microdissection 56
Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease 55
Le cheratosi attiniche. Classificazione istopatologica 55
KRAS mutation testing on endoscopic biopsy of primary colorectal cancer 55
HER2 analysis in sporadic thyroid cancer of follicular cell origin 55
Caveolin-1 immuno-expression in human gastric cancer: histopathogenetic hypotheses. 54
AgNOR analysis of gastric carcinoids. 54
Caveolina-1 nel carcinoma gastrico e nella mucosa gastrica normale adiacente: studio immunoistochimico e valutazioni istopatogenetiche. 54
Nucleolar organizer regions (NORs) in dysplastic and neoplastic epithelial lesions of the conjunctiva 54
A survey of laser-assisted microdissection systems in pathologic and forensic applications. 54
The immunoexpression of Tn, SIALYL-Tn and T antigens in chronic active gastritis in relation to Helicobacter pylori infection 53
Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry 52
Immunohistochemical expression of metallothionein in primary hepatocellular carcinoma and liver metastases 52
IMMUNOCYTOCHEMICAL DETECTION OF DNA TOPOISOMERASE TYPE-II IN PRIMARY BREAST CARCINOMAS - CORRELATION WITH CLINICOPATHOLOGICAL FEATURES 52
Identification of Lf mRNA isoforms from human neoplastic cells harvested by laser microdissection. 52
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 52
Discordance Rate of HER2 Status in Primary Gastric Cancer and Synchronous Lymph Node Metastases: Its Impact on Therapeutic Decision and Clinical Management 52
IMMUNOLOCALIZATION OF LACTOFERRIN IN HUMAN SPORADIC RENAL CELL CARCINOMAS: AN INVESTIGATION BY MONO- AND POLYCLONAL ANTISERA. 51
Immunolocalization of lactoferrin in surgically resected pigmented skin lesions 51
Metastasis risk assessment in breast cancer (BC): a preliminary study of pre-metastatic niche (PMN) in nonmetastatic nodes 51
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 51
THE VALUE AND SIGNIFICANCE OF NUCLEOLAR ORGANIZER REGION (AGNOR) PROTEINS IN ULCERATIVE-COLITIS AND ADENOCARCINOMAS OF THE LARGE-BOWEL 50
Relationship between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis 50
Human Papillomavirus Types Distribution in Eastern Sicilian Females with cervical lesions. A Correlation with Colposcopic and Histological Findings. 50
Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes? 49
Extended RAS mutation testing on wild-type KRAS exon 2 metastatic colorectal cancer. 49
Heterogeneity of KRAS mutational status in colorectal adenocarcinomas with a mucinous component 49
Morphological and biomolecular characteristics of subcentimetric invasive breast carcinomas: a Sicilian multicentric retrospective analysis. 49
Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas 48
The application of AgNOR technique on glycol-methacrylate embedded human normal and pathological tissues. 48
Molecular and clinical analysis of predictive biomarkers to anti-EGFR inhibitors in metastatic colorectal cancer (mCRC): Interaction among early tumor shrinkage, skin toxicities, and RAS status. 48
null 48
Expression of lactoferrin mRNA in human breast cancer cells selected by laser-microdissection. 48
Immunoespressione delle proteine del mismatch repair ed analisi dei microsatelliti mediante microdissezione in adenomi colo-rettali insorti in pazienti con HNPCC 47
Immunohistochemical detection of metallothionein in carcinomatous and normal human gastric mucosa 47
Immunolocalization of lactoferrin in pigmented lesions of the skin. 47
AgNOR quantity in actinic keratosis and squamous cell carcinoma of the skin. 47
Le cheratosi attiniche. Classificazione istopatologica. 47
Laser microdissection and DNA typing of cells from single hair follicles 46
MMR proteins immunoexpression and microsatellite analysis by laser-microdissection in HNPCC-associated adenomas 46
Molecular diagnostics of cancer disposition in adenomas of HNPCC patients. The importance of laser-microdissection 46
Single sperm cell isolation by laser microdissection 46
Heterogeneity of K-Ras mutation status in colorectal adenocarcinomas with a mucinous component. 46
BRAF status in papillary microcarcinomas of the thyroid gland: A brief review 46
Immunohistochemical expression of pS2 protein in transitional cell bladder carcinomas. 45
AgNOR analysis of actinic keratosis basal and squamous cell carcinomas of the skin. 45
The expression of adiponectin receptors Adipo-R1 and Adipo-R2 is associated with an intestinal histotype and longer survival in gastric carcinoma. 45
Immunohistochemical and biomolecular aspects in craniopharyngiomas: is there any suggestion to improve their treatment ? 45
Morphometric analysis of AgNORs in uveal malignant melanoma 44
Microsatellite analysis in adenomas presenting in patients affected by HNPCC: a study by laser-assisted microdissection 44
The AgNOR quantity as prognostic parameter in choroidal melanomas: a standardised analysis 44
PCNA/cyclin expression in breast carcinomas: its relationship with Ki-67, ER, PgR immunostainings and clinico-pathological aspects. 44
Relationships between HER2 status and proliferation rate in breast cancer assessed by immunohistochemistry, fluorescence in situ hybridisation and standardised AgNOR analysis. 44
Microsatellite analysis in adenomas presenting in patients affected by HNPCC: a study by laser-assisted microdissection. 44
Immunohistochemical demonstration of lactoferrin in human neoplastic tissues. 44
LMD as a forensic tool in a sexual assault casework: LCN DNA typing to identify the responsible 43
Letter to the editor regarding: A comparative study of glial fibrillary acidic protein (GFAP)-like immunoreactivity in the retinas of some representative vertebrates. 43
Liquid biopsy in non-small cell lung cancer: a comparison between different methodologies to detect somatic mutations 43
The AgNOR count in ulcerative colitis with and without dysplasia 42
The AgNOR quantity as new promising prognostic tool in pathology of parathyroid glands. 42
KRAS mutation testing on different areas of primary colorectal adenocarcinomas with mucinous component 42
Risk evaluation in breast cancer: a preliminary study of pre-metastatic niche in 252 negative lymphnodes. 42
Lactoferrin immunoexpression in endometrial carcinomas: Relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival 42
Totale 5.549
Categoria #
all - tutte 23.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.609


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019212 0 0 0 0 128 18 33 10 8 3 4 8
2019/20201.477 258 115 8 107 17 154 171 173 22 177 260 15
2020/20211.234 158 16 271 87 70 135 24 135 24 154 106 54
2021/20221.186 11 135 17 32 25 18 50 45 18 289 179 367
2022/20233.387 253 246 120 310 262 346 57 187 1.423 37 100 46
2023/2024453 90 126 63 103 71 0 0 0 0 0 0 0
Totale 8.492